issue

Nov 4, 2024

Volume 20 Number 21

In this issue of EuroIntervention, in original research, a novel sirolimus-coated balloon is compared to a paclitaxel-coated balloon in the treatment of patients with de novo coronary lesions; an investigation into the natural history of newly developed calcified nodules and their implications for clinical outcomes; a comparison of ultrathin-strut vs thin-strut DES or DEB for treating DES in-stent restenosis; and in trial design, the TAILORED-CHIP trial which is examining the timing of antiplatelet therapy in high-risk PCIs; news from EAPCI; and more...

Original Research

A randomised trial of sirolimus- versus paclitaxel-coated balloons for de novo coronary lesions
Scheller B, Mangner N, Jeger R, Afan S, Mahfoud F, Woitek F, Fahrni G, Schwenke C, Schnorr B, Kleber F
10.4244/EIJ-D-23-00868

Editorial comment

Natural history of a newly developed calcified nodule: incidence, predictors, and clinical outcomes
Sugizaki Y, Matsumura M, Chen Y, Tsukui T, Shlofmitz E, Thomas S, Malik S, Dakroub A, Singh M, Shin D, Granville M, Busch J, Wolff E, Miraglia G, Moses J, Khalique O, Cohen D, Mintz G, Shlofmitz R, Jeremias A, Ali Z, Maehara A
10.4244/EIJ-D-24-00362
Treatment of in-stent restenosis with ultrathin-strut versus thin-strut drug-eluting stents or drug-eluting balloons: a multicentre registry
De Filippo O, Wańha W, Sanavia T, Januszek R, Giacobbe F, Campo G, Pinxterhuis T, Capodanno D, Tomasiewicz B, Iannaccone M, Leone A, Wolny R, Bruno F, Patti G, Musumeci G, Liccardo G, Verardi R, Roubin S, Tarantini G, Kuzma L, Perl L, Gagnor A, Reczuch K, Conrotto F, Tuttolomondo D, Ploumen E, Niezgoda P, Caglioni S, Omedè P, Greco A, Kubica J, Gil R, Piccolo R, Kornowski R, Bil J, Morena A, Zocca P, Pennone M, Gasior M, Jaguszewski M, von Birgelen C, Fariselli P, De Ferrari G, Wojakowski W, D’ascenzo F
10.4244/EIJ-D-24-00491

Trial Design

Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CHIP trial
Park H, Kang D, Ahn J, Yun S-C, Park K, Kang S, Suh J, Bae J, Park S, Cho JH, Suh J, Lee B, Rha S, Won H, Jang J, Kim MH, Lee CH, Ahn YK, Oh J, Bae J, Park CS, Choi J, Lee J, Lee S, Hur S, Kwon O, Park S, Park D
10.4244/EIJ-D-24-00437

Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved